Amgen Inc. 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-23 4:20 pm Sale | 2024-08-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS | AMGEN INC AMGN | 0 0.000% | -4,910,000 (Position Closed) | Filing |
| 2022-12-02 06:01 am Purchase | 2022-11-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS | AMGEN INC AMGN | 4,910,000 6.000% | 4,910,000 (New Position) | Filing |